François Tison
Scientific articles
-
Genome sequence analyses identify novel risk loci for multiple system atrophy
Neuron. 2024-05-01.
10.1016/j.neuron.2024.04.002 -
Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries
Movement Disorders. 2024-02-29. 39(3) : 571-584.
10.1002/mds.29718 -
Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions
eBioMedicine. 2024-01-01. 99 : 104931.
10.1016/j.ebiom.2023.104931 -
Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment
Parkinsonism & Related Disorders. 2021-05-01. 86 : 124-132.
10.1016/j.parkreldis.2021.03.027 -
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial
Mov Disord. 2021-04-01. 36(7) : 1704-1711.
10.1002/mds.28569 -
Clinical relevance of brain atrophy subtypes categorization in memory clinics
Alzheimer's & Dementia. 2020-12-15. 17(4) : 641-652.
10.1002/alz.12231 -
A Phase 2 Randomized Trial of Asleep versus Awake Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease
Stereotact Funct Neurosurg. 2020-11-30. 99(3) : 230-240.
10.1159/000511424 -
Correction to: Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort (Journal of Neural Transmission, (2020), 127, 12, (1607-1617), 10.1007/s00702-020-02249-0)
J Neural Transm. 2020-10-21. 128(6) : 871-872.
10.1007/s00702-020-02264-1 -
Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort
J Neural Transm. 2020-09-02. 127(12) : 1607-1617.
10.1007/s00702-020-02249-0 -
Dynamique de l’atrophie des sous-champs hippocampiques dans le vieillissement et la maladie d’Alzheimer.
Revue Neurologique. 2020-09-01. 176 : S2.
10.1016/j.neurol.2020.01.054 -
Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial
JPD. 2020-07-28. 10(3) : 1171-1184.
10.3233/JPD-202033 -
Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study
Neurobiology of Disease. 2020-06-01. 139 : 104813.
10.1016/j.nbd.2020.104813 -
The late stage of Parkinson’s –results of a large multinational study on motor and non-motor complications
Parkinsonism & Related Disorders. 2020-06-01. 75 : 91-96.
10.1016/j.parkreldis.2020.05.016 -
Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK Study
Drugs Aging. 2020-01-10. 37(3) : 215-223.
10.1007/s40266-019-00740-2 -
Multiple System Atrophy: Recent Developments and Future Perspectives
Mov Disord. 2019-11-06.
10.1002/mds.27894 -
Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment
Neurology. 2019-09-30. 93(14) : 630-639.
10.1212/WNL.0000000000008208 -
A Spatial Decision Eye-Tracking Task in Patients with Prodromal and Mild Alzheimer’s Disease
JAD. 2019-09-17. 71(2) : 613-621.
10.3233/JAD-190549 -
Evolution of brain atrophy subtypes during aging predicts long-term cognitive decline and future Alzheimer’s clinical syndrome
Neurobiology of Aging. 2019-07-01. 79 : 22-29.
10.1016/j.neurobiolaging.2019.03.006 -
Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease
J Neural Transm. 2019-05-16. 126(6) : 789-793.
10.1007/s00702-019-02015-x -
Acute toxic limbic encephalopathy following glyphosate intoxication
Neurology. 2019-02-08. : 10.1212/WNL.0000000000007115.
10.1212/wnl.0000000000007115 -
Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type.
Parkinsonism & Related Disorders. 2019-02-01.
10.1016/j.parkreldis.2019.02.006 -
Impact of sleep apnea syndrome on survival in patients with multiple system atrophy.
Parkinsonism & Related Disorders. 2017-02-01. 35 : 92-95.
10.1016/j.parkreldis.2016.12.013 -
Vascular parkinsonism
Current Opinion in Neurology. 2004-02-01. 17(1) : 49-54.
10.1097/00019052-200402000-00009 -
Hypertension and progressive supranuclear palsy: Is everything so clear?
Mov Disord.. 2004-01-01. 19(10) : 1259-1261.
10.1002/mds.20275 -
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
Mov. Disord.. 2000-05-01. 15(3) : 531-536.
10.1002/1531-8257(200005)15:3<531::aid-mds1017>3.0.co;2-c -
Parkinsonism as a result of a giant aneurysm
Mov. Disord.. 1999-01-01. 14(1) : 159-161.
10.1002/1531-8257(199901)14:1<159::AID-MDS1029>3.0.CO;2-M